Research Analysts’ Weekly Ratings Updates for Labcorp (LH)

A number of firms have modified their ratings and price targets on shares of Labcorp (NYSE: LH) recently:

• 10/14/2025 – Labcorp was given a new $320.00 price target on by analysts at Truist Financial Corporation.
• 10/8/2025 – Labcorp had its “buy (b-)” rating reaffirmed by analysts at Weiss Ratings.
• 10/3/2025 – Labcorp had its price target raised by analysts at Evercore ISI from $300.00 to $305.00. They now have an “outperform” rating on the stock.
• 10/2/2025 – Labcorp had its price target raised by analysts at Barclays PLC from $275.00 to $290.00. They now have an “equal weight” rating on the stock.
• 9/27/2025 – Labcorp had its “buy (b-)” rating reaffirmed by analysts at Weiss Ratings.
• 8/25/2025 – Labcorp was given a new $311.00 price target on by analysts at Robert W. Baird.

Labcorp Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, December 11th. Investors of record on Wednesday, November 26th will be issued a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 1.0%. The ex-dividend date is Wednesday, November 26th. Labcorp’s payout ratio is 31.79%.

Insider Buying and Selling

In related news, EVP Der Vaart Sandra D. Van sold 3,903 shares of Labcorp stock in a transaction on Wednesday, August 13th. The shares were sold at an average price of $271.42, for a total value of $1,059,352.26. Following the transaction, the executive vice president owned 2,274 shares in the company, valued at $617,209.08. This trade represents a 63.19% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Dwight Gary Gilliland sold 2,000 shares of the business’s stock in a transaction on Wednesday, July 30th. The stock was sold at an average price of $264.95, for a total transaction of $529,900.00. Following the transaction, the director directly owned 6,656 shares of the company’s stock, valued at approximately $1,763,507.20. This represents a 23.11% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 15,046 shares of company stock valued at $4,074,692 in the last quarter. Company insiders own 0.84% of the company’s stock.

Labcorp Holdings, Inc engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.